Customer Story: Emergent BioSolutions Implements The SA25 Aseptic Filling Workcell

Emergent BioSolutions faced a critical challenge at its Winnipeg manufacturing site: ensuring future production capacity while maintaining strict regulatory compliance. In 2016, the company undertook a major quality plan overhaul, identifying that its conventional filling system—operating in an open Grade A cleanroom—could no longer meet evolving industry standards or long-term operational goals. This realization prompted a strategic shift toward advanced filling technologies designed to enhance sterility assurance, streamline processes, and support scalability. This case study highlights how proactive investment in modern equipment can mitigate compliance risks and position facilities for sustainable growth in a competitive biopharmaceutical landscape.

Learn how this transformation unfolded and the lessons learned for manufacturers navigating similar challenges.